Lupin Ltd — M&A Activity 2021

Mar 31, 2021

==> picture [74 x 87] intentionally omitted <==

==> picture [199 x 97] intentionally omitted <==

==> picture [75 x 87] intentionally omitted <==

**a)**Nameofthetargetentity, details inbriefsuch assize,turnover etc.:	_i)_Name**ofthe Target entity:AIOCDPharmasofttechAwacsPrivate Limited ('AWACS').TrikaalMediinfortechPrivate Limited ('Trikaal')_ii) Details of_Target****entity:**AWACSisengagedinthebusinessofpharmaceuticaldatacollectionandmarket research.Trikaal is50%ownerofAWACSandholdscertainintellectual propertyinrelationtoA WACS's business.
**b)**Whethertheacquisitionwouldfall withinrelatedparty transaction(s)andwhetherthepromoter/promotergroup/groupcompanieshaveanyinterestin the entitybeingacquired? If yes,natureofinterestanddetails thereofandwhetherthe sameisdoneat"Arms-length";	Not arelatedpartytransaction.
**c)**Industrytowhichtheentitybeingacquiredbelongs;	Healthcare services.
**d)**Objectsandeffectsofacquisition (includingbutnotlimitedto,disclosureof reasonsforacquisitionoftargetentity, if its businessisoutsidethemainlineofbusinessofthelistedentity;	A stepbyABCDTechnologiesLLP(toberenamedaslndoHealth ServicesLLP)towardstheinitiativewithanobjectivetofacilitate,enableandpromoteefficiencyandGoodDistributionPracticesincluding digitizinghealthcareinfrastructure in India, inter alia,insupportoftheNationalDigital Health MissionofGovernmentofIndia ('Business'). Theacquisitionisandwillbedonebyits whollyownedentityDigiHealth TechnologiesLLP.
**e)**Briefdetailsofanygovernmentalorregulatoryapprovalsrequiredfortheacquisition;	NotApplicable.
f)Indicativetimeperiodforcompletionoftheacquisition;	Theacquisitionof66.02%ofshareholdinginAWACS (directandindirecttogether) hasbeencompletedon301hofMarch,2021.Theacquisition of 33.44%oftheshareholdingin AWACS(indirect)isenvisagedtobecompletedoverthecourseofnextfewmonths subjecttofulfilmentofcertaintermsandconditions.Theremaining0.54%oftheshareholdinginAWACS (indirect)islikelytobeacquiredafterfiveyears(FY:2026- 27).
**g)**Natureofconsideration-whethercashconsiderationorshareswapanddetailsofthesame;	Cash ConsiderationpayablebyDigiHealth TechnologiesLLP.
**h)**Costofacquisitionorthepriceatwhichthesharesareacquired;	Thecostofacquisition for thecombinedtransactionofAWACSandTrikaalisapproximatelyINR75crores foracquisitionof100%stake in AWACSandTrikaal (directandindirecttogether).
IN LIMITED

==> picture [74 x 85] intentionally omitted <==

I)Perand	centageofshareholding/controlacquired/ornumberofsharesacquired;	Please refer	tothe resp	onse providedinpointf)a		bove.
J)Brietermdatturnhasinfo	fbackgroundabouttheentityacquiredinsofproducts/lineofbusinessacquired,	(i)Aboutthe	entities:			euticaldatan intellectual
	eofincorporation, historyoflast 3 yearsover,countryinwhichtheacquiredentity	A WACSis collection	engagediandmarke	nthebusinessofpharmac t research.
	presenceandanyothersignificantrmation (in brief);	Trikaalis50propertyi	%owneronrelationt	fAWACSandholds c ertaioA WACS's business
		(ii)DateofI	ncorporatio	.n:
		AWACS:S	eptember	21.2007
		Trikaal: Jan	uary 3, 20	07
		(iii)TurnoverAWACS:	historyofl	ast 3 years:
		2019-20202018-201	: 15,31.95,9:16,15,30,	103697
		2017-2018	:16,30,86,	020
		Trikaal:2019-2020	:Nil
		2018-20192017-2018(iv) Country:	:Nil: 1,10,00,0	00
		India

==> picture [82 x 78] intentionally omitted <==